Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Histogen Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 13 | 14 | +1 |
| Shares | 108.5K | 174.8K | +66.3K (+61.1%) |
| Value | $90.4K | $211.1K | +$120.6K (+133.4%) |
New holders (4)
Institutions that held Histogen Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 26,536 | $32.0K | 0.00% |
| Susquehanna International Group, LLP | 15,487 | $18.7K | 0.00% |
| Global Retirement Partners, LLC | 15 | $12 | 0.00% |
| Northwestern Mutual Wealth Management Co | 1 | $1 | 0.00% |
Sold out (3)
Institutions that held Histogen Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Jane Street Group, LLC | 13,182 | $10.9K |
| Renaissance Technologies LLC | 10,600 | $9.00K |
| Benjamin F. Edwards & Company, Inc. | 5 | $0 |